{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:50:42Z","timestamp":1788022242255,"version":"build-2784847793"},"reference-count":40,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Dermatol"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Artificial intelligence (AI) has many applications in numerous medical fields, including dermatology. Although the majority of AI studies in dermatology focus on skin cancer, there is growing interest in the applicability of AI models in inflammatory diseases, such as psoriasis. Psoriatic disease is a chronic, inflammatory, immune-mediated systemic condition with multiple comorbidities and a significant impact on patients\u2019 quality of life. Advanced treatments, including biologics and small molecules, have transformed the management of psoriatic disease. Nevertheless, there are still considerable unmet needs. Globally, delays in the diagnosis of the disease and its severity are common due to poor access to health care systems. Moreover, despite the abundance of treatments, we are unable to predict which is the right medication for the right patient, especially in resource-limited settings. AI could be an additional tool to address those needs. In this way, we can improve rates of diagnosis, accurately assess severity, and predict outcomes of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to provide an up-to-date literature review on the use of AI in psoriatic disease, including diagnostics and clinical management as well as addressing the limitations in applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the databases MEDLINE, PubMed, and Embase using the keywords \u201cAI AND psoriasis OR psoriatic arthritis OR psoriatic disease,\u201d \u201cmachine learning AND psoriasis OR psoriatic arthritis OR psoriatic disease,\u201d and \u201cprognostic model AND psoriasis OR psoriatic arthritis OR psoriatic disease\u201d until June 1, 2023. Reference lists of relevant papers were also cross-examined for other papers not detected in the initial search.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our literature search yielded 38 relevant papers. AI has been identified as a key component in digital health technologies. Within this field, there is the potential to apply specific techniques such as machine learning and deep learning to address several aspects of managing psoriatic disease. This includes diagnosis, particularly useful for remote teledermatology via photographs taken by patients as well as monitoring and estimating severity. Similarly, AI can be used to synthesize the vast data sets already in place through patient registries which can help identify appropriate biologic treatments for future cohorts and those individuals most likely to develop complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There are multiple advantageous uses for AI and digital health technologies in psoriatic disease. With wider implementation of AI, we need to be mindful of potential limitations, such as validation and standardization or generalizability of results in specific populations, such as patients with darker skin phototypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/50451","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T23:42:02Z","timestamp":1720741322000},"page":"e50451","source":"Crossref","is-referenced-by-count":8,"title":["AI in Psoriatic Disease: Scoping Review"],"prefix":"10.2196","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8667-3529","authenticated-orcid":false,"given":"Richard","family":"Barlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-0290","authenticated-orcid":false,"given":"Anthony","family":"Bewley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-1945","authenticated-orcid":false,"given":"Maria Angeliki","family":"Gkini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/mind\/LIX.236.433"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18880"},{"key":"ref3","unstructured":"Artificial intelligence (AI) at HHSU.S. Department of Health and Human Services2024-07-26https:\/\/www.hhs.gov\/about\/agencies\/asa\/ocio\/ai\/index.html"},{"key":"ref4","unstructured":"Artificial intelligence in healthcare: applications, risks, and ethical and societal impactsEuropean Parliament20222024-07-26https:\/\/www.europarl.europa.eu\/thinktank\/en\/document\/EPRS_STU(2022)729512"},{"key":"ref5","unstructured":"The Topol Review2024-07-26https:\/\/topol.hee.nhs.uk\/the-topol-review\/"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocz192"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00100"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00462-6"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_418_20"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5015"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.11.948"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3386"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20482"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.07.011"},{"key":"ref15","unstructured":"LandiHGoogle debuts AI-powered app to help consumers identify common skin conditionsFierce Healthcare20212023-09-10https:\/\/www.fiercehealthcare.com\/tech\/google-previews-ai-dermatology-tool-to-help-consumers-identify-skin-conditions"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0842-3"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1364\/BOE.10.000879"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15965"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2015.11.013"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2196\/44932"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18354"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19039"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2113872"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18741"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3171"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847312"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2013.11.001"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06672-6"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.05.002"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060951"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldab016"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.93"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20663"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00372-0"},{"key":"ref35","unstructured":"ScoviakMAI diagnostics fall short in skin of colorDermatology Times20212023-09-10https:\/\/www.dermatologytimes.com\/view\/ai-diagnostics-fall-short-in-skin-of-color"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.884"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2196\/37611"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18875"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2196\/36823"},{"key":"ref40","unstructured":"European approach to artificial intelligenceShaping Europe's Digital Future2023-10-22https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/european-approach-artificial-intelligence"}],"container-title":["JMIR Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/derma.jmir.org\/2024\/1\/e50451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:33:16Z","timestamp":1782840796000},"score":1,"resource":{"primary":{"URL":"https:\/\/derma.jmir.org\/2024\/1\/e50451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2196\/50451","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.50451","asserted-by":"object"}]},"ISSN":["2562-0959"],"issn-type":[{"value":"2562-0959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}